Article metrics

Download PDFPDF

799 Durable responses and immune activation with intratumoral electroporation of pIL-12 plus pembrolizumab in actively progressing anti-PD-1 refractory advanced melanoma: KEYNOTE 695 interim data

 

Online download statistics by month:

Online download statistics by month: November 2020 to May 2022

AbstractFullPdf
Nov 2020306034
Dec 202066010
Jan 20215604
Feb 202111806
Mar 2021102010
Apr 202164010
May 202131014
Jun 2021007
Jul 20211014
Aug 20210017
Sep 20210014
Oct 202184023
Nov 2021106015
Dec 20216206
Jan 202294010
Feb 20225609
Mar 2022106016
Apr 2022104012
May 2022140013
Total14960244